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Abstract
Rationale, aims and objectives: Routine outcome monitoring (ROM) was developed to
establish the outcome of psychotherapeutic and pharmacological treatments through
repeated assessments before, during and after treatment. Although standardization of psy-
chiatric assessments and their reference values are essential for patient care, for various
ROM instruments reference values are not available. The aim of the Leiden ROM Study is
to generate reference values for 22 ROM instruments, covering generic and specific mood,
anxiety and somatoform (MAS) disorders, for the general population. This article describes
the extensive process of recruitment, as well as baseline characteristics of patient versus
non-patient groups.
Method: Cross-sectional study in randomly selected participants aged 18–65 years from
the Dutch population, included through general practitioners.
Results: Extensive demographic, psychosocial, mental health, and biological data from
1302 participants, recruited via general practitioners, were collected during a two-hour
standardized assessment including observer-rated and self-report scales. These data will be
compared with corresponding data from 7840 patients with psychopathology who were
referred to secondary care. On-going quality control and calibration ensured maintenance
of high quality during data collection.
Conclusions: This reference group study for mental health assessments is the first study of
this size carried out in the Netherlands. The results of this study are expected to be of value
to secondary psychiatric care because they allow the indication of progress in health,
treatment effect and possible termination of treatment. Additionally, the reference values
can be used by primary care physicians as decision threshold for referral to specialized
mental health care and vice versa.
Introduction
Routine outcome monitoring (ROM) was developed to enhance
the effectiveness of psychiatric care. ROM routinely measures
treatment outcomes using different outcome measures that are
both generic and disorder specific. It provides clinicians with
information on the type and severity of psychopathology and feed-
back on treatment efficacy. Additional benefits are its use in
research and benchmarking [1–3]. However, several ROM instru-
ments lack reference values that provide optimal discrimination
between the ‘healthy’ and the ‘diseased’, indicating whether the
patient has progressed to a range of psychological health similar
to non-patients, while not necessarily free of all symptoms. Also,
with outcome variables often varying between different gender
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and age groups, reference values are the key to determining
whether a group or an individual scores above or below average
for their gender and age [4,5]. Anchoring ROM instruments in
population-based reference values makes clinical and scientific
interpretations more meaningful and is consistent with practice in
other areas of medicine [6,7]. Furthermore, reference values are
useful to determine when primary care doctors could refer their
patients to secondary care and vice versa.
In order to study the relationship between psychosocial factors,
genetic variation, the effect of the hypothalamic-pituitary-adrenal
(HPA) axis stress system, and the occurrence and course of mood,
anxiety and somatoform (MAS) disorders, the Leiden Routine
Outcome Monitoring Study was designed to generate a large ROM
database [8,9].
The present ROM Reference Group Study was designed to
provide reference values for 22 ROM in the general practice popu-
lation in the Netherlands. This may help to facilitate assessment
of a clinically significant change of treatment effects, defined as
returning to normal functioning.
A secondary aim was to collect saliva from a large general
population control group in order to facilitate research on genetic
characteristics (DNA) and the HPA axis stress system in relation
to the development and course of MAS disorders. Genetic factors
and a deregulated HPA axis are involved in the aetiology of
MAS disorders. Twin studies [10,11] have shown that mood
and anxiety disorders are for 30–40% determined by hereditary
factors. Furthermore, dysregulation of the HPA axis is believed to
be linked with the pathophysiology of depression [12–14] and
anxiety disorders [15,16].
The present study describes the methods and objectives of the
ROM Reference Group Study, as well as baseline characteristics
of patient versus non-patient groups.
Methods
Participants
The ROM reference group was recruited to serve as a comparison
for the ROM patient group. Therefore, the aim for this reference
group was that it should be representative of the ROM population
referred for suspected (but not necessarily diagnosed with) MAS
disorders, treated at the psychiatric outpatient department of the
Leiden University Medical Center (LUMC) or at the mental health
clinics of Rivierduinen (RD; hereafter referred to as the ‘ROM pa-
tient group’). The sample was stratified for gender, age and urban-
ization level to be representative of the ROM patient group [17].
A total of 1302 participants (18–65 years) was recruited, 1294
of whom provided complete datasets (Fig. 1). In order to recruit
persons reflecting normal functioning with different levels of sub-
threshold psychopathology, recruitment took place via general
practices. In the Netherlands, because 99.9% of the general popu-
lation is registered with a general practitioner (GP) [18], the prac-
tice registers provide a convenient frame for sampling the local
general population. Eight university-affiliated general practices
with a total of 14 000 enlisted patients in the vicinity of Leiden
were involved. In order to form a non-patient control group and to
secure the reliability and validity of the collected data, four exclu-
sion criteria were formulated: (1) treatment in a secondary psychi-
atric care centre in the last 6 months for psychiatric problems
and/or dependence on alcohol or drugs; (2) hearing impairment,
limited cognitive abilities, such as aphasia, severe dyslexia or
dementia; (3) illiteracy or insufficient mastery of the Dutch lan-
guage; and (4) a terminal disease.
The study protocol was approved by the Ethical Review Board
(ERB) of the LUMC and all subjects signed informed consent.
Figure 1 Flow chart depicting recruitment of the ROM reference and patient groups.
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Since 2002, the LUMC and RD, serving a region of more than
1 million people, have implemented ROM [1]. ROM baseline
assessments in the ROM patient group started in 2002 and are
ongoing. Specially trained psychiatric research nurses assessed
80% of the patients (totalling 8357 ROM patients), 7840 of whom
were aged 18–65 years. To facilitate research on genetic charac-
teristics (DNA) and the HPA axis stress system (cortisol day
curves), the MASHBANK (biobank for MAS disorders and the
HPA axis) was founded at the LUMC and RD in 2007 after
approval by the ERB of the LUMC. In this biobank, saliva samples
are stored from 1000 consenting MAS patients. Figure 1 shows
the multistage recruitment flow of the ROM reference group, as
well as recruitment of the ROM patient group.
Participants of the ROM reference group were offered the full
set of generic instruments. Since the total number of instruments
was too extensive and all participants were already asked to com-
plete the depression instruments, random samples of 50% each
were asked to complete the anxiety instruments or the somato-
form instruments, with even ratios of males and females in each
subgroup. Thus, four subgroups were established: males-anxiety;
females-anxiety; males-somatoform; females-somatoform. A
sample size of at least 120 per subgroup was considered to
provide adequate power to yield reference values [19]. In genetic
research, an adequate sample size is imperative because of the
low frequency of several genetic variants and the problem of
multiple testing. Furthermore, a sample size of 1000 DNA donat-
ing participants was deemed to be required [20]. With an antici-
pated response rate of 30%, about 4500 people were approached.
In order to get a ROM-representative sample, four age groups
were used: 18–25; 26–40; 41–55; 56–65 years, and the reference
group was sampled accordingly.
Procedures
In order to recruit the ROM reference group, the eight partici-
pating GPs first screened their patient lists for those that met the
inclusion/exclusion criteria. Subsequently, randomly selected
appropriate persons were invited to participate by a letter (sent
by regular postal service) by their GPs that was followed by an
announced telephone call by the research team to ask for their
participation. Objections against this call could be indicated on
an enclosed reply card. To compensate for possible seasonal
influences, recruitment took place all year long (between
November 2009 and January 2011). Location was the LUMC
clinic site and, if appreciated, at the participant’s home or in the
GP’s practice. Similar to the ROM patient assessment proce-
dures, dedicated Web-based computer software was used for the
administration of all instruments and to prevent missing data
within instruments. It was also used for data collection and
storage, and for creation of summary variables [1]. Touch
screens were used to accommodate computer-illiterate partici-
pants. A personal data entry program was developed in database
software to organize identification codes for general, ROM and
MASHBANK data, and to randomly assign the two specific
instrument packets (depression and anxiety; depression and
somatoform) to participants.
For participants of the ROM reference group, the interview
started with an explanation of the study, and signing of the
informed consent form. This was followed by a check and assess-
ment of personal details and demographic data, general health,
cognitive functioning and physical examination (i.e. body weight,
height and blood pressure). Saliva samples were collected in par-
ticipants who additionally consented to this biobank substudy.
Next, computerized observer-rated and self-report questionnaires
were completed. Finally, participants completed an evaluation
form and received a gift voucher of €30 (for their time and coop-
eration) and a travel allowance.
In the ROM Reference Group Study, 3 psychiatric research
nurses, 3 psychologists (Master’s degree level) and 11 Master’s
students in psychology were extensively trained and tested at the
start of and during the reference group study to ensure uniform and
adequate quality and reliability. Topics were Mini-International
Neuropsychiatric Interview Plus, version 5.0.0-R (MINI-Plus
5.0.0.) and abbreviated Comprehensive Psychopathological Rating
Scale (vCPRS) interviewing methods, Global Assessment of Func-
tioning Scale (GAF) scoring, use of QuestManager and additional
knowledge about MAS disorders and MASHBANK. Three full
days of training (by the primary investigator, SvM, two psychia-
trists and two ROM-trained nurses) took place. Each interviewer
also observed at least three interviews, and the first two interviews
were carried out under supervision (one of which observed by the
primary investigator). Supervision regarding interview techniques,
problematic behaviour of the participants and scoring rating scales,
to improve inter-rater reliability, took place every 2 months. Video
recordings of interviews were used to further calibrate assessments
between interviewers. Using a semi-structured scoring scale, a
qualitative assessment was done and was found to be very good in
all but one potential interviewer. This latter interviewer with insuf-
ficient skills was considered unsuitable and no longer took part.
The ROM patient group was assessed by two trained ROM psy-
chiatric research nurses; their training has been described in detail
elsewhere [1].
Assessments
The ROM reference group assessment comprised measurement
of physical health, saliva collection and observer-rated and self-
report instruments. Measurement of physical health indicators
comprised blood pressure, heart rate and body mass index, and
health-related factors (i.e. general health, chronic diseases,
smoking status and alcohol consumption).
From participants who agreed to participate in the MASH-
BANK substudy, saliva was collected enabling cortisol measure-
ments and DNA isolation. HPA axis activity was assessed by free
cortisol measurements using seven saliva samples per participant,
self-collected at home. Procedures are similar to that described
in detail elsewhere [14,16,21]. Saliva for DNA isolation was col-
lected in DNA Genotek kits (Oragene, DNA Genotek, Ottawa, OT,
Canada). Measuring cortisol and DNA concentrations in saliva has
many advantages over measurements in blood samples. Saliva
collection is non-invasive and can be repeated frequently. Further-
more, storage of the material requires no special treatment because
DNA and cortisol levels remain stable at room temperature.
The assessments comprised 25 instruments concerning demo-
graphic and personal characteristics, psychosocial function, physi-
cal health and psychopathology (Table 1), 22 of which require
reference values. Except for the 48-item Symptom Questionnaire
(SQ-48), all tested ROM instruments are internationally used and
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validated. The generic self-report instrument SQ-48 was recently
developed by our research group in order to assess mood, anxiety,
somatoform symptoms, hostility and vitality.
Statistical analyses
Reference values will be calculated for all instruments, including
subscales. Both for patients and for the reference group reference
values will be determined for all subjects combined, as well as for
four groups: young males (aged 18–40 years), older males (aged
41–65 years), young females (aged 18–40 years) and older
females (aged 41–65 years). Means and SDs, 5th, 25th, 50th, 75th
and 95th percentiles, and receiver operating characteristics (ROC)
analyses (i.e. the cut-off score with the optimal sensitivity and
specificity, and area under curve values) will be computed. Refer-
ence limits are often defined by two SDs below and above the
mean if distributions are Gaussian. Since most distributions of
total scores on the scales tested in the healthy reference group are
expected to be strongly (positively) skewed, percentiles are more
appropriate [22–24], with the lower interval bounded only by the
95th percentile being a common reference group [25]. However,
trade-offs exist between the sensitivity and specificity, with a
higher cut-off value (i.e. higher percentile boundary) having
a relatively high specificity but low sensitivity, and vice versa
(Fig. 2; left panel). ROC analyses will provide additional cut-offs
reflecting discriminatory power [26].
Figure 2 (right panel) shows psychopathology expressed as the
number of MINI diagnoses of MAS disorders in the ROM refer-
ence group and the ROM patient group.
Results
Figure 1 shows recruitment of the ROM reference group and the
ROM patient group. A total of 1302 persons were interviewed
and their data analyzed. The duration of the interview was shorter
(range 1.5–2.0 hours) in participants without psychopathology
and longer (range 2.5–4.0 hours) in participants with psychopa-
thology. Although the interview was extensive, all participants
finished the full assessment. Additional telephone calls after the
initial mailing proved to have a motivating effect on the subse-
quent response rates. Patients from the first GP only received the
invitation by mail (no telephone call) and showed a response of
16.3%. We tried to contact patients recruited from all other GPs
by telephone. The response to the initial mail, before the tele-
phone call by the research team, was 15.9% (768 of 4840). The
response to the telephone call and the mail was 45.3% of those
the research team managed to contact (1613 of 3557). A total of
67 responders were not included because of a surplus in some of
the age groups, or because of logistical reasons at the end of the
study. Therefore, the response of persons contacted was 37.3%
(1302 of 3490). However, when taking into account the large
group of 1283 persons that could not be contacted by letter or
telephone, the response of persons mailed was 26.9% (1302 of
4840). A total of 148 persons were excluded: 36 who consented
following the mail (treated in a secondary psychiatric care centre,
or insufficient mastery of the Dutch language), 101 after a tele-
phone call (for similar reasons) and 11 during or after the inter-
view (for similar reasons, as well as severe dyslexia or cognitive
impairment).
Table 2 presents the sociodemographic characteristics of the
ROM reference group (n = 1294) and the ROM patient group
(n = 7840), 543 of whom did not complete the demographic inven-
tory. Gender and age distributions in both samples were similar,
and the mean age in both samples was 2 years higher for men
than for women. Compared to the ROM patient group, the ROM
reference group less often lived in a rural area, was less often
divorced, separated or widowed, was less often unemployed or
disabled and had a higher educational level.
The aim for the ROM reference group was that it should be a
‘normal’ group but allowed for prevalent psychopathology that
could be treated in the GP practices, and therefore, showed some
(co-)morbidity of psychiatric illness but to a much lesser extent
Figure 2 Left panel: the expected distribution of many of the 22 mood, anxiety and somatoform (MAS) disorder-assessment instruments in the ROM
reference and patient groups; Right panel: the actual distribution of the number of MAS disorders in the ROM reference and patient groups. In the
ROM reference group, above the 95th percentile (P95; i.e. reference value) the probability is high for a person to meet the terms of psychopathology.
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than the ROM patient group (Fig. 2). According to the MINI-Plus,
9.4% of the ROM reference group met criteria for one or more
MAS disorders compared to 74.5% in the ROM patient group. A
single MAS diagnosis was present in 7.8% participants and in
47.9% ROM patients. In the ROM reference group, anxiety dis-
orders were most prevalent followed by somatoform disorders. In
the ROM patient group, major depression was the most prevalent
disorder followed by anxiety disorders. Thus, the ROM reference
group showed lower co-morbidity than the ROM patient group and
reflected psychiatric morbidity within the general population
(Table 3, Fig. 2).
Discussion
This cross-sectional study in a randomly selected sample from a
Dutch general population (aged 18–65 years) aimed to provide
reference values for ROM instruments (and to serve as a control
group for the biobank) for patients with MAS disorders. It is the
first reference group study for mental health assessments of this
size carried out in the Netherlands. The large sample size and
extensive assessment of psychopathology provide data that, by
comparison with data from ROM patients, is expected to yield
reliable reference values for ROM instruments (across a wide age
range) that are not yet available. Genetic and HPA axis data enable
further biological research into MAS disorders.
Comparison of the demographics of the ROM reference and
patient groups showed a similar gender and age distribution, as
expected given the sampling frame. There was a slightly (uninten-
tional) different urbanization level. However, the effects of urba-
nicity on psychopathology are generally of limited significance
in international [27] and Dutch (NEMESIS; Bijl et al. 1998)
co-morbidity studies. Moreover, differences between rural and
urban areas are declining in the Netherlands. Compared to the
ROM patient group, the ROM reference group showed higher
levels of education and less unemployment or work-related
Table 2 Sociodemographic characteristics of the ROM reference group






Male 484 (37.4%) 2700 (37.0%)
Female 810 (62.6%) 4597 (63.0%)
Age (mean, SD) in years 40.2 (12.5) 37.9 (12.3)
18–25 194 (15.0%) 1508 (20.7%)
26–40 479 (37.0%) 2715 (37.2%)
41–55 448 (34.6%) 2370 (32.5%)
56–65 173 (13.4%) 704 (9.6%)
Urbanization level
Urban 806 (62.3%) 3955 (54.2%)
Rural 488 (37.7%) 3342 (45.8%)
Marital status
Married/cohabitating 890 (68.8%) 3721 (50.9%)
Divorced/separated/widow 78 (6.0%) 989 (13.6%)
Single 326 (25.2%) 2587 (35.5%)
Housing situation
Living alone 200 (15.7) 1693 (23.2%)
Living with partner 902 (69.7) 3762 (51.6%)
Living with family 192 (14.8) 1842 (25.2%)
Educational status
Lower 295 (22.8) 3133 (42.9%)
Higher 999 (77.2) 4164 (57.1%)
Employment status
Employed part-time 508 (39.3%) 1737 (23.9%)
Employed full-time 554 (42.8%) 1702 (23.3%)
Unemployed/retired 197 (15.2%) 2118 (27.1%)
Work-related disability 35 (2.7%) 1874 (25.7%)
Ethnic background
Dutch 1160 (89.6%) 5981 (80.0%)
Other ethnicity 134 (10.4%) 1316 (18.0%)
ROM, routine outcome monitoring.
Table 3 Mood, anxiety and somatoform
(co-)morbidity in the ROM reference group
(n = 1302) and the ROM patient group
(n = 7840)
ROM reference group ROM patient group
Frequency Per cent Frequency Per cent
None 1193 90.6 1998 25.5
Anxiety 54 4.1 1568 20.0
Mood 7 0.5 1682 21.5
Somatoform 42 3.2 500 6.4
Anxiety and mood 7 0.5 1377 17.6
Anxiety and somatoform 9 0.7 209 2.7
Mood and somatoform 1 0.1 275 3.5
Anxiety and mood and somatoform 2 0.2 231 2.9
Total anxiety 72 5.5 3385 43.2
Total mood 17 1.3 3565 45.5
Total somatoform 54 4.2 1215 15.5
Total 1302 100.0 7840 100.0
Anxiety disorders comprise panic disorder with or without agoraphobia, agoraphobia without
history of panic disorder, specific phobia, social phobia, obsessive–compulsive disorder, post-
traumatic stress disorder and generalized anxiety disorder, and anxiety disorders NOS.
Mood disorders comprise major depressive disorders, bipolar disorder, dysthymia.
Somatoform disorders comprise somatization disorder, undifferentiated somatoform disorder, pain
disorder (chronic), hypochondriasis, body dysmorphic disorder and conversion disorder.
ROM; routine outcome monitoring.
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disability. Accordingly, both co-morbidity studies [4,27] reported
the highest morbidity rates for those with the lowest levels of
education, and the lowest morbidity rates for those with the highest
levels of education. Mental disorders were reported to be least
prevalent among people in paid employment. Overall, morbidity
and co-morbidity were strongly associated with occupational dis-
ability and unemployment.
As expected, morbidity of any current MAS disorder in the
reference group was much lower than in the ROM patient group.
Anxiety disorders were equally prevalent in the ROM reference
group compared to a study in the general practice population
(n = 1778) in the Netherlands (5.5%) [28]. Mood disorders were
less prevalent in the reference group (1.3%) than in the general
practice population (4.1%) as well as compared to prevalence rates
in various European countries, ranging between 4.6% and 7.4%
[29]. The current prevalence rate for somatoform disorders
was 4.2% in our ROM reference group, compared to 16.1% in a
general practice population [28]. This discrepancy can probably be
ascribed to differences in the recruitment procedure, as the latter
study included consultation seeking patients, whereas we included
a random sample of the general practice population. Also, in our
study, most interviews took place in hospital versus home inter-
views in the study of De Waal et al. Another explanation could be
differences in the ascertainment of depressive and somatoform
disorders (MINI-Plus 5.0.0. in our study versus the Scan diagnos-
tic interview in the study of De Waal et al.). Moreover, selection
and non-response bias may have occurred in our study, as
depressed people are often less inclined to participate because of
fatigue or loss of energy. Co-morbidity rates of psychopathology
in the reference group were similar to those reported in the Dutch
co-morbidity study [4] and very low compared to the ROM patient
group.
Several issues need to be considered when analyzing reference
values for psychiatric assessment scales from healthy popula-
tions. Reference values need to be accurate and reproducible.
First, in samples derived from the general population many of the
total scores do not have a bell-shaped Gaussian distribution, but
rather an asymmetrical, right-sided, skewed distribution. When
log-Gaussian curves are also not normally distributed, means
with (1.96 times) SDs cannot be used to yield the central 95% of
the reference population of subjects. Rather, percentile values
(e.g. 97.5th, 95th or 90th) can be used, as this non-parametric
method makes no specific assumption regarding the distribution
from which the data are obtained. Nevertheless, extreme values
can still have a profound effect in defining reference values, and
therefore, sample sizes (in subgroups) of at least 120 are needed
(for 90% confidence intervals) to reduce the amount of uncer-
tainty [19,30,30]. Second, outliers can be removed before the
analysis, using outlier detection methodology. For example, if the
difference between the extreme and the next most extreme value
exceeds 1/3rd of the range, the extreme value can be deleted (i.e.
the Dixon test method) [19]; this may yield better reference
values. However, an attempt should first be made to determine
whether these extremes are errors in the assessment procedure.
Third, there may be a profound influence from healthy and non-
healthy (psychiatrically ill individuals) individuals on the estima-
tion of reference values. About 10% narrower reference intervals
will be derived from samples that excluded non-healthy subjects
[31] but could make the reference range unreasonably narrow.
Therefore, we chose to study a ‘control’ group rather than a
‘healthy’ group. Overall, there are many trade-offs between the
different parametric, transformed parametric and non-parametric
methodologies.
Reference values for psychiatric instruments are essential for
patient care. In this ROM reference group, data were collected
enabling the calculation of reference values for 22 ROM instru-
ments that often lack these values because recruiting valid groups
of reference subjects is costly and time intensive. These reference
values are of major clinical importance because they can help to
weigh the severity of symptoms and provide criteria that signify
the transition from illness to health, and potential treatment termi-
nation. They can also be used by primary care physicians for
referral to secondary care, and vice versa. Additionally, reference
material to facilitate research on genetic characteristics (DNA) and
the HPA axis stress system was collected.
Our study has specific strengths. First, to yield reliable and
stable reference values, the group has to be of sufficient size and
representative for the patient group of interest. Tests for decisions
at the individual level such as therapy indication or monitoring
require a sample size of at least 250 subjects per reference group
standardized for age and sex [32,33]. The size of the group
and four subgroups surpassed this number and the previously
described size of the 120 recommended participants [19,30], even
when partitioning the test subjects by sex and age groups. Second,
the diagnostic interview was structured leading to better identifi-
cation of diagnostic co-morbidity than unstructured interviews
[34]. Next to self-report data, observational data were collected
using the MINI-Plus. This approach provided comprehensive
clinical information according to international standards (DSM-
IV). Third, standardization of the interviews was assured, as both
observation scales and self-report questionnaires were adminis-
tered via a Web-based computer program, implying a fixed order
in administration of instruments with no instruments skipped or
data missing, and no errors because of manually entering data.
Fourth, recruitment through GPs allowed for a good description of
the sample characteristics. Furthermore, contacting possible par-
ticipants by telephone presumably increased the response rate.
Finally, an ongoing quality control and calibration among inter-
viewers ensured that a high quality was maintained during data
collection.
The present study also has some limitations. First, because
recruitment of the ROM reference and patient group took place in
the Dutch region of Leiden, reference values may not be directly
internationally generalizable. Moreover, because ethnic partici-
pants formed a minority, generalizability of reference values to
other countries and ethnicities is limited. Second, children and
elderly were not included, thus requiring their own reference
group studies. Third, non-response was significant, involving a
possible, unknown bias. Finally, information about the character-
istics of those who did not participate is lacking. It is unclear
whether non-responders differed in a systematic way from the
participating subjects.
In conclusion, we succeeded in collecting extensive data from
1302 persons from the general population, enabling the calculation
of reference values for 22 ROM instruments. The results of the
reference values are expected to become available within the next
2 years and will be useful for current and future diagnostic and
research purposes in patients with MAS disorders.
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